LONDON, March 24, 2026, 13:47 GMT
Beazley shares were quoted at 1,264 pence by 1327 GMT on Tuesday, flat on the day, after fresh takeover-period disclosures showed large investors adjusting positions as Zurich Insurance’s agreed 8.1 billion pound deal for the insurer moves into its next phase. Vanguard disclosed a 5.03% holding, while D.E. Shaw reported a 1.62% exposure through derivatives. 1
That matters now because Beazley has traded ex-dividend since March 19, meaning new buyers no longer qualify for the separate 25 pence payout. The cleaner comparison is Zurich’s 1,310 pence cash leg, not the 1,335 pence headline value, and at 1,264 pence the stock sits about 46 pence, or 3.5%, below that cash consideration, a gap that suggests investors are still pricing time and execution risk. 2
Under the March 2 terms, Beazley shareholders are entitled to a total value of 1,335 pence a share, made up of 1,310 pence in cash and a 25 pence interim dividend. The scheme document, the formal circular for a UK court-approved takeover, is due within 28 days of the announcement unless the Takeover Panel allows more time; shareholder meetings are expected in April and closing in the second half of 2026, subject to regulatory and antitrust approvals. 3
Tuesday’s Vanguard filing showed the fund manager held 30.13 million Beazley shares, or 5.03%, after buying 17,357 shares and selling 19,620 on March 23. These Rule 8 forms are the disclosures required during an offer period for investors with 1% or more of the relevant securities. 4
D.E. Shaw, in a separate filing, disclosed exposure to 9.75 million shares, or 1.62%, through cash-settled derivatives, contracts that track the stock without requiring outright ownership. J.P. Morgan Markets, Beazley’s corporate broker and financial adviser, separately disclosed no position. 5
Zurich has already moved to reduce one obvious uncertainty: funding. The Swiss insurer said the Beazley purchase would be financed with about $3 billion of existing cash, roughly $2.9 billion of new debt and a $5 billion equity raise, and Reuters reported it completed a 3.9 billion Swiss franc share sale on March 3. 6
The offer came just before Beazley reported a 19% drop in annual pretax profit, hurt by softer pricing and slower growth in cyber insurance, though the company said it saw no material hit from the Middle East conflict at that point. The result gave investors a fresh look at the standalone business Zurich is buying. 7
The deal has also kept the spotlight on London-listed specialty insurance peers, including Hiscox and Lancashire. Reuters reported in February that analysts saw room for more sector dealmaking, with Moody’s Ratings’ Salman Siddiqui saying softening pricing “sets the stage for a multi-year consolidation cycle,” while RBC’s Ben Cohen said buyers were trying to future-proof their business models. 8
Zurich Chief Executive Mario Greco said on March 2 the combination would create the “world’s leading Specialty underwriter” with about $15 billion of specialty gross written premiums on a combined basis, the industry’s measure of premiums written before claims and reinsurance costs. In plain terms, that means a bigger platform in harder-to-place insurance lines such as cyber, marine, aviation, space and fine art. 9
But the gap has not gone away. The transaction still needs court approval, shareholder backing and regulatory and antitrust clearances, and any slip in the scheme timetable or approvals process could widen the distance between Beazley’s market price and Zurich’s cash terms. 3
